Can knowledge of germline markers of toxicity optimize dosing and efficacy of cancer therapy?
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Can knowledge of germline markers of toxicity optimize dosing and efficacy of cancer therapy?
Authors
Keywords
-
Journal
Biomarkers in Medicine
Volume 6, Issue 3, Pages 349-362
Publisher
Future Medicine Ltd
Online
2012-06-27
DOI
10.2217/bmm.12.19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Variants in the Dihydropyrimidine Dehydrogenase, Methylenetetrahydrofolate Reductase and Thymidylate Synthase Genes Predict Early Toxicity of 5-Fluorouracil in Colorectal Cancer Patients
- (2013) MH Kristensen et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer
- (2011) Fotios Loupakis et al. BMC CANCER
- A genotype-directed phase I–IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer
- (2011) E Marcuello et al. BRITISH JOURNAL OF CANCER
- Erlotinib ‘dosing-to-rash’: a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer
- (2011) A C Mita et al. BRITISH JOURNAL OF CANCER
- Clinical implications of UGT1A1*28 genotype testing in colorectal cancer patients
- (2011) Katerina Shulman et al. CANCER
- Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib
- (2011) Jenny J. Kim et al. CANCER
- Meta-analysis of docetaxel-based doublet versus docetaxel alone as second-line treatment for advanced non-small-cell lung cancer
- (2011) Wei-Xiang Qi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacogenomic Contribution to Drug Response
- (2011) Roshawn G. Watson et al. CANCER JOURNAL
- Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1*28 and/or UGT1A1*6 polymorphisms
- (2011) Taroh Satoh et al. CANCER SCIENCE
- Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal Cancer
- (2011) M. J. Deenen et al. CLINICAL CANCER RESEARCH
- Cancer Pharmacogenomics
- (2011) S W Paugh et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics: From Bench to Byte— An Update of Guidelines
- (2011) J J Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Use of Genomic Information to Optimize Cancer Chemotherapy
- (2011) Federico Innocenti et al. SEMINARS IN ONCOLOGY
- Increased Risk of High-Grade Hypertension With Bevacizumab in Cancer Patients: A Meta-Analysis
- (2010) V. Ranpura et al. AMERICAN JOURNAL OF HYPERTENSION
- Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
- (2010) Dawn L. Hershman et al. BREAST CANCER RESEARCH AND TREATMENT
- Mortality in the Randomized, Controlled Lung Intergroup Trial of Isotretinoin
- (2010) J. J. Lee et al. Cancer Prevention Research
- Phase I Oncology Studies: Evidence That in the Era of Targeted Therapies Patients on Lower Doses Do Not Fare Worse
- (2010) R. K. Jain et al. CLINICAL CANCER RESEARCH
- Dose-Dependent Association between UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Low Doses Also Increase Risk
- (2010) Z.-Y. Hu et al. CLINICAL CANCER RESEARCH
- Germline Genetic Variation, Cancer Outcome, and Pharmacogenetics
- (2010) Linda Coate et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4599
- (2010) Suzanne E. Dahlberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study
- (2009) L. Noens et al. BLOOD
- Pharmacogenetics in Oncology: A Promising Field
- (2009) D. Houtsma et al. CURRENT PHARMACEUTICAL DESIGN
- Translating the cancer genome into clinically useful tools and strategies
- (2009) F. Innocenti et al. Disease Models & Mechanisms
- Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status
- (2009) Gabriele Stocco et al. Expert Opinion On Drug Safety
- Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer
- (2009) Giuseppe Toffoli et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral Methotrexate/6-mercaptopurine may be Superior to a Multidrug LSA2L2 Maintenance Therapy for Higher Risk Childhood Acute Lymphoblastic Leukemia
- (2009) Kjeld Schmiegelow et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Dose Escalation Methods in Phase I Cancer Clinical Trials
- (2009) Christophe Le Tourneau et al. JNCI-Journal of the National Cancer Institute
- Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia
- (2009) K Schmiegelow et al. LEUKEMIA
- Risk of High-Grade Skin Rash in Cancer Patients Treated with Cetuximab – an Antibody against Epidermal Growth Factor Receptor: Systemic Review and Meta-Analysis
- (2009) Xiao Su et al. ONCOLOGY
- Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment
- (2009) Ursula Amstutz et al. PHARMACOGENOMICS
- Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
- (2009) Emma C. Davies et al. PLoS One
- Skin toxicities associated with epidermal growth factor receptor inhibitors
- (2009) Tianhong Li et al. Targeted Oncology
- SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap
- (2008) A. D. Johnson et al. BIOINFORMATICS
- UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma
- (2008) Chun-Yu Liu et al. CANCER
- Vascular Endothelial Growth Factor Gene Polymorphisms Associated with Prognosis for Patients with Colorectal Cancer
- (2008) J. G. Kim et al. CLINICAL CANCER RESEARCH
- Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia
- (2008) G Stocco et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Dose Selection in Phase I Studies: Why We Should Always Go for the Most Effective
- (2008) Ian E. Haines JOURNAL OF CLINICAL ONCOLOGY
- Dose Selection in Phase I Studies: Why We Should Always Go for the Top
- (2008) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacogenomic and Pharmacokinetic Determinants of Erlotinib Toxicity
- (2008) Charles M. Rudin et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100
- (2008) Bryan P. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy
- (2008) Paul L. Nguyen et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Genetic and Nongenetic Factors for Fluorouracil Treatment-Related Severe Toxicity: A Prospective Clinical Trial by the German 5-FU Toxicity Study Group
- (2008) Matthias Schwab et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment
- (2008) Chin-Lun Huang et al. LUNG CANCER
- Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival
- (2008) Konstantinos Dassoulas et al. MOLECULAR CARCINOGENESIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now